ArticleJournal of gastrointestinal cancer2023
Evaluation of Prognostic Factors for Unresectable or Recurrent Gastric Cancer Treated with Nivolumab.
Kenji Ishido et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it